Close

Reata Pharmaceuticals (RETA) Reports Q2 Loss of $0.05/Share

Go back to Reata Pharmaceuticals (RETA) Reports Q2 Loss of $0.05/Share
(NASDAQ: RETA) Delayed: 172.36 --0 (-0%)
Previous Close $172.36    52 Week High $41.60 
Open $172.36    52 Week Low $11.03 
Day High $172.36    P/E N/A 
Day Low $172.36    EPS $0.00 
Volume 160,267